Synthetic cannabinoid receptor agonists inhibit tumor growth and metastasis of breast cancer.
about
S100A7 enhances mammary tumorigenesis through upregulation of inflammatory pathwaysModulation of cellular redox homeostasis by the endocannabinoid systemAnticancer mechanisms of cannabinoidsEndocannabinoids as Guardians of MetastasisCannabinoids as therapeutic agents in cancer: current status and future implicationsSpice drugs are more than harmless herbal blends: a review of the pharmacology and toxicology of synthetic cannabinoidsAn Integrated Genome-Wide Systems Genetics Screen for Breast Cancer Metastasis Susceptibility GenesCannabinoids, endocannabinoids, and cancerPreclinical and Clinical Assessment of Cannabinoids as Anti-Cancer AgentsCrosstalk between chemokine receptor CXCR4 and cannabinoid receptor CB2 in modulating breast cancer growth and invasionMinireview: recent developments in the physiology and pathology of the lysophosphatidylinositol-sensitive receptor GPR55.Novel role of cannabinoid receptor 2 in inhibiting EGF/EGFR and IGF-I/IGF-IR pathways in breast cancer.Differential role of psoriasin (S100A7) in estrogen receptor α positive and negative breast cancer cells occur through actin remodelingC-X-C motif chemokine 12/C-X-C chemokine receptor type 7 signaling regulates breast cancer growth and metastasis by modulating the tumor microenvironment.Fluorinated cannabinoid CB2 receptor ligands: synthesis and in vitro binding characteristics of 2-oxoquinoline derivativesCannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition.Anandamide inhibits breast tumor-induced angiogenesisIn vivo type 2 cannabinoid receptor-targeted tumor optical imaging using a near infrared fluorescent probeFAAH inhibition enhances anandamide mediated anti-tumorigenic effects in non-small cell lung cancer by downregulating the EGF/EGFR pathway.RAGE mediates S100A7-induced breast cancer growth and metastasis by modulating the tumor microenvironmentAnti-nicastrin monoclonal antibodies elicit pleiotropic anti-tumour pharmacological effects in invasive breast cancer cells.Cannabinoid receptors, CB1 and CB2, as novel targets for inhibition of non-small cell lung cancer growth and metastasis.Synthetic cannabinoids: epidemiology, pharmacodynamics, and clinical implications.The Antitumor Activity of Plant-Derived Non-Psychoactive Cannabinoids.Expression and functional relevance of cannabinoid receptor 1 in Hodgkin lymphoma.The endocannabinoid system and cancer: therapeutic implication.Modulation of the tumor microenvironment and inhibition of EGF/EGFR pathway: novel anti-tumor mechanisms of Cannabidiol in breast cancer.Tumor-suppressive effects of psoriasin (S100A7) are mediated through the β-catenin/T cell factor 4 protein pathway in estrogen receptor-positive breast cancer cells.A synergistic interaction of 17-β-estradiol with specific cannabinoid receptor type 2 antagonist/inverse agonist on proliferation activity in primary human osteoblasts.Latest advances in novel cannabinoid CB(2) ligands for drug abuse and their therapeutic potential.Modulation of breast cancer cell viability by a cannabinoid receptor 2 agonist, JWH-015, is calcium dependent.Simultaneous Activation of Induced Heterodimerization between CXCR4 Chemokine Receptor and Cannabinoid Receptor 2 (CB2) Reveals a Mechanism for Regulation of Tumor ProgressionCombined antiproliferative effects of the aminoalkylindole WIN55,212-2 and radiation in breast cancer cells.Critical appraisal of the potential use of cannabinoids in cancer management.Inhibition of fatty acid amide hydrolase activates Nrf2 signalling and induces heme oxygenase 1 transcription in breast cancer cellsThe endocannabinoid system and sex steroid hormone-dependent cancers.Transcriptional Network Architecture of Breast Cancer Molecular SubtypesOff-target cannabinoid effects mediated by GPR55.Receptor-dependent and receptor-independent endocannabinoid signaling: a therapeutic target for regulation of cancer growth.The evolving role of the endocannabinoid system in gynaecological cancer.
P2860
Q24598566-5B4E0B75-398A-4240-873B-2401C5EF63CBQ26744211-AE81E49D-CC35-470E-8F59-85107434851AQ26750399-6F15ABEB-D7E5-4BFF-B114-96A7EF1E979EQ26766163-3E1853A4-1B6B-4821-88BB-0CB5F3D76E22Q26866298-34044EB7-9928-4F76-A15D-ED36770E239EQ27010555-C8D1BD8C-7956-43D6-B73C-DA49EF035573Q27308942-4BCEA590-04C3-4633-867F-41F04AD824F3Q27694715-1BEA457E-BA6B-47C9-9860-E6584E638F39Q28075903-20BDE728-B5C6-4F67-9797-225EA3106060Q28476823-56C61216-D727-4A3D-A1D8-26CFA1D886C9Q33636763-100BB071-6448-45AC-9363-C3ADF9C1AE9FQ33728086-A81BBDE4-73EA-4D76-B472-6D566CFC7AAEQ33804642-33249FD6-D017-4964-B12F-29CA3081484CQ33827026-A9EFBE33-0D53-4083-AAD2-7534A9649BD9Q34004234-B999CCB5-7F5D-4CA0-9BB3-31D6E7D1864BQ34049715-C231564B-C6FD-4997-B8A9-DE388F22D26FQ34074335-07A52C13-B392-4BAA-A37E-18CD1CD5A932Q34257434-76121DA1-888B-4D54-9339-62CBCC2ED125Q34419405-4B648783-4138-46A4-9D72-1D965845C13FQ34457327-07BCEEBC-AE25-4CBD-A299-8E99849E9612Q34468644-6B7D04E6-A179-4760-9DC9-ACF247064025Q34513406-22ACB610-2CA4-4173-BE48-176B7AE37BD1Q34617484-C340EDCA-3E7A-4F63-BAD2-01C5B2AE8E50Q34669534-2099D063-D2E0-41FB-AD4B-E9E882EC378AQ35069709-DC5FED48-4506-46B7-971D-07B91DA0A807Q35193299-B9400F11-3FC6-4E7E-82B5-AD62268AC41FQ35287890-D4FC02C3-4B7A-4C8A-BF4B-868CA51A075EQ35639956-45AB7023-0341-4FEF-B328-6EFDC51B9FF4Q35803402-BFF5B48D-9A67-4F45-9AC3-08656AEC6A5EQ36408464-D5E8687C-01CE-4762-9256-E8B032B19857Q36843205-51F23924-56FD-4325-9BB2-F30DC5312BF3Q36876322-55DCB92F-EE00-4388-B8FB-E3BD2AEE7059Q36876630-357CF19D-6319-45C9-9E90-CBB1141048AAQ37164208-59835303-61ED-4440-A2FA-F5DD10A1056EQ37219066-1C2A0D0A-B427-4B19-AD6E-E303F6A49B59Q37393042-B93CC9D0-3309-4FBA-8151-AD495B14864FQ37428430-62F3A7DF-949C-46B9-ABC6-46E53CB8A70BQ37995375-83913DC5-7442-4AED-90C9-7A60C4A3CBFCQ38052298-D5ACE2D5-1B79-47A3-9A21-A07425B6D204Q38469671-343ACAB8-1D66-4D5C-ABD7-4FE2D60FB479
P2860
Synthetic cannabinoid receptor agonists inhibit tumor growth and metastasis of breast cancer.
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Synthetic cannabinoid receptor ...... d metastasis of breast cancer.
@ast
Synthetic cannabinoid receptor ...... d metastasis of breast cancer.
@en
Synthetic cannabinoid receptor ...... d metastasis of breast cancer.
@nl
type
label
Synthetic cannabinoid receptor ...... d metastasis of breast cancer.
@ast
Synthetic cannabinoid receptor ...... d metastasis of breast cancer.
@en
Synthetic cannabinoid receptor ...... d metastasis of breast cancer.
@nl
prefLabel
Synthetic cannabinoid receptor ...... d metastasis of breast cancer.
@ast
Synthetic cannabinoid receptor ...... d metastasis of breast cancer.
@en
Synthetic cannabinoid receptor ...... d metastasis of breast cancer.
@nl
P2093
P2860
P921
P1476
Synthetic cannabinoid receptor ...... d metastasis of breast cancer.
@en
P2093
Anju Preet
Caroline E Bass
Gustavo Leone
Mohd W Nasser
Ramesh K Ganju
Sanford H Barsky
Zahida Qamri
P2860
P304
P356
10.1158/1535-7163.MCT-09-0448
P577
2009-11-03T00:00:00Z